Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

“I believe we've hit not only the cell of origin for lung adenocarcinoma, but also the pathway of origin,” says Kadara. This cancer originates in the epithelial cells that line the lung’s ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...

Castellano, also a researcher, explains, "This protein helps to maintain lung epithelial cells—those that cover the inner surface of the lungs—in an undifferentiated state," that is ...

Rein Therapeutics initiates RENEW phase 2 trial of LTI-03 in patients with idiopathic pulmonary fibrosis: Austin, Texas Tuesday, May 13, 2025, 18:00 Hrs [IST] Rein Therapeutics (R ...

which then persuades the epithelial cells of the lung to recruit neutrophils, a type of white blood cell that causes ...

In healthy lungs, specialized cells called fibroblasts help repair lung tissue. But in people with IPF, some fibroblasts and nearby epithelial cells stop functioning properly. These so-called ...